MedPath

Visceral fat and adipocytokine profile in Japanese patients with type2 diabetes mellitus treated with DPP-4 inhibitors.

Not Applicable
Conditions
Type 2 diabetes
Registration Number
JPRN-UMIN000008250
Lead Sponsor
Kawasaki Medical School Hospital
Brief Summary

Per test planner retirement

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who were added other OADs during the course of the trial. 2) Patients on corticodteroid. 3) Patients with renal impairment or moderate to severe hepatic dysfunction. 4) Patients with heart failure. 5) Patients treated with insulin or who absolutely needs insulin treatment. 6) Patients with current malignancy. 7) Patients with endocrine disorders. 8) Patients with severe mental illness. 9) Patients with pregnancy or lactating. 10) An excessive alcohol drunker. 11) Patients under the contraindication of each drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Decrement of visceral fat area/ visceral fat/subcutaneous fat rate, Change in adipocytokine/PWV
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath